Opportunity Information: Apply for CDC RFA IP14 1403
Apply for CDC RFA IP14 1403
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Economic Studies of Vaccines and Immunization Policies, Programs, and Practices for Adults" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.185 Immunization Research, Demonstration, Public Information and EducationTraining and Clinical Skills Improvement Projects.
- This funding opportunity was created on Apr 30, 2014 and posted on Apr 28, 2014.
- Applicants must submit their applications by Jun 5, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $150,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $150,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible applicants for this FOA are included in this section. 1.Eligible Applicants States, political subdivisions of States, and other public and nonprofit private entities.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Economic Studies of Vaccines and Immunization Policies, Programs, and Practices for Adults" (Funding Opportunity Number CDC-RFA-IP14-1403) is a CDC discretionary funding announcement released as a cooperative agreement. Its central aim is to strengthen how adult vaccination decisions are made at the state and local level by pulling together what is already known about the economics of adult vaccines and turning that information into something practical that health departments can use when resources are tight.
At the core of the project are two connected deliverables. First, the funded work is expected to produce a clear, well-organized summary of existing economic evidence on adult vaccines, drawing from both published studies in the scientific literature and relevant unpublished economic data developed by CDC. This includes synthesizing information on cost effectiveness and related economic measures for vaccines that are routinely recommended for adults by the CDC's Advisory Committee on Immunization Practices (ACIP). The intent is not simply to list studies, but to consolidate and interpret the evidence in a way that highlights what is known, where findings are consistent or inconsistent, and where gaps remain.
Second, the project must develop a quantitative decision-support tool intended for real-world use by state and local public vaccinating entities, such as health departments that run or coordinate adult immunization activities. The announcement emphasizes decision analysis and other appropriate analytic methods, with the goal of helping programs prioritize which adult populations and which vaccines to focus on to improve vaccination coverage. The underlying problem the CDC is trying to address is that adult immunization programs often face limited budgets, staffing, and operational capacity, and they need a defensible way to decide where investments will produce the most benefit. In practice, this suggests a tool that can compare options, weigh tradeoffs, and support planning decisions in a structured, data-informed way rather than relying on ad hoc judgment.
The funded activity is categorized under health, and it sits within CFDA 93.185 (Immunization Research, Demonstration, Public Information and Education; Training and Clinical Skills Improvement Projects). The award structure is very specific: CDC expected to make one award total, with an estimated total funding amount of $150,000. The award ceiling and floor are both listed as $150,000, indicating a single fixed-size award rather than a range. There is no cost sharing or matching requirement, meaning applicants were not required to contribute non-federal funds as a condition of the award.
Eligibility is broad and includes states, political subdivisions of states, and other public and nonprofit private entities, with the announcement also referencing additional eligibility clarification elsewhere in the full FOA. Because the mechanism is a cooperative agreement, applicants should generally expect substantial CDC involvement during the period of performance compared with a standard grant, typically through collaboration on technical direction, data alignment, or review of key deliverables, consistent with how cooperative agreements are commonly administered.
Key dates show this was a time-limited opportunity posted on April 28, 2014, with an original and final closing date of June 5, 2014, and an archive date of July 5, 2014. For administrative or access issues, the listed point of contact is the CDC Procurement and Grants Office (PGO) at 770-488-2700 and pgotim@cdc.gov.
Overall, the opportunity is best understood as an applied evaluation and decision-support project focused on adult immunization economics: compile the best available economic evidence (including CDC-developed unpublished inputs) and translate it into a usable quantitative tool that helps state and local health agencies prioritize adult vaccination strategies in a constrained-resource environment.
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The opportunity is titled "Economic Studies of Vaccines and Immunization Policies, Programs, and Practices for Adults."
What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number is CDC-RFA-IP14-1403.
Which federal agency is offering this opportunity?
This is a discretionary funding announcement from the Centers for Disease Control and Prevention (CDC).
What type of funding mechanism is used?
The announcement is issued as a cooperative agreement, which typically means CDC is expected to have substantial involvement during the project period (for example, collaboration on technical direction, alignment to CDC data inputs, and review of deliverables).
What is the main purpose of the project?
The central aim is to strengthen how adult vaccination decisions are made at the state and local level by consolidating economic evidence on adult vaccines and converting that evidence into practical decision support that health departments can use when resources are limited.
What problem is CDC trying to address through this project?
The project targets the reality that adult immunization programs often operate with limited budgets, staffing, and operational capacity. CDC is seeking a defensible, structured approach to help programs decide where investments are likely to produce the most benefit rather than relying on ad hoc judgment.
What are the two core deliverables expected from the funded work?
The project centers on two connected deliverables:
- A clear, well-organized summary of existing economic evidence on adult vaccines (including interpretation and identification of gaps).
- A quantitative decision-support tool designed for real-world use by state and local public vaccinating entities to help prioritize adult vaccination strategies.
What should the economic evidence summary include?
The summary is expected to synthesize economic evidence for vaccines routinely recommended for adults by the CDC Advisory Committee on Immunization Practices (ACIP). It should draw from both:
- Published studies in the scientific literature, and
- Relevant unpublished economic data developed by CDC.
It is intended to consolidate and interpret findings (not merely list studies), highlighting where results align, where they differ, and where evidence gaps remain.
What kinds of economic measures are expected to be covered?
The announcement specifically references synthesizing information on cost effectiveness and related economic measures for adult vaccines recommended by ACIP.
What is the intended audience for the decision-support tool?
The decision-support tool is intended for state and local public vaccinating entities, such as health departments that run or coordinate adult immunization activities.
What is the tool expected to help users do?
The tool is meant to help programs prioritize which adult populations and which vaccines to focus on to improve vaccination coverage, especially in constrained-resource settings. It is expected to support comparisons of options, tradeoffs, and planning decisions using a structured, data-informed approach.
Are specific analytic methods required for the decision-support tool?
The announcement emphasizes decision analysis and other appropriate analytic methods, with the intent of producing a quantitative tool that supports prioritization and planning decisions.
What topic area does this funding opportunity fall under?
The funded activity is categorized under health, with a focus on applied evaluation and decision support in adult immunization economics.
What CFDA program is associated with this opportunity?
This opportunity is associated with CFDA 93.185 (Immunization Research, Demonstration, Public Information and Education; Training and Clinical Skills Improvement Projects).
How many awards did CDC expect to make?
CDC expected to make one award total.
What is the total estimated funding amount?
The estimated total funding amount is $150,000.
What are the award ceiling and award floor?
Both the award ceiling and the award floor are listed as $150,000, indicating a single fixed-size award rather than a range.
Is cost sharing or matching required?
No. The announcement states there is no cost sharing or matching requirement.
Who is eligible to apply?
Eligibility is described as broad and includes:
- States
- Political subdivisions of states
- Other public entities
- Nonprofit private entities
The announcement also notes that additional eligibility clarification is referenced elsewhere in the full FOA.
When was the opportunity posted?
The opportunity was posted on April 28, 2014.
What was the application deadline?
The original and final closing date listed is June 5, 2014.
Is this opportunity still open?
No. The opportunity was time-limited and shows an archive date of July 5, 2014.
Who should be contacted for administrative or access issues?
For administrative or access issues, the listed point of contact is the CDC Procurement and Grants Office (PGO):
- Phone: 770-488-2700
- Email: pgotim@cdc.gov
What makes this opportunity "applied" rather than purely academic?
The announcement is framed around producing practical outputs for health departments: a synthesized evidence summary that interprets real economic findings and a quantitative tool that supports real-world prioritization decisions in adult immunization programs facing resource constraints.
Does the evidence summary include only published literature?
No. The summary is expected to incorporate both published studies and relevant unpublished economic data developed by CDC.
Which vaccines are in scope for the evidence synthesis?
The scope includes vaccines that are routinely recommended for adults by the CDC Advisory Committee on Immunization Practices (ACIP).
What is the overall theme of the project in one sentence?
It is an adult immunization economics project designed to compile the best available economic evidence and translate it into a usable quantitative decision-support tool for state and local vaccination planning under constrained resources.
Browse more opportunities from the same category: Health
Next opportunity: R3 State Wildlife Grants (TO STATE FG AGENCIES ONLY)
Previous opportunity: ROSES 2014 Atmospheric Composition Modeling and Analysis
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA IP14 1403
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA IP14 1403) also looked into and applied for these:
| Funding Opportunity |
|---|
| Voluntary Medical Male Circumcision (VMMC), Early Infant Circumcision (EIMC) Service Delivery and Support to the Government of the Kingdom of Swaziland Apply for RFA 674 14 000001 Funding Number: RFA 674 14 000001 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $24,500,000 |
| Disseminating and Implementing Evidence from Patient Centered Outcomes Research in Clinical Practice Using Mobile Health Technology (R21) Apply for RFA HS 14 010 Funding Number: RFA HS 14 010 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $150,000 |
| Emerging Pandemic Threats Program 2, Preparedness Apply for RFA OAA 14 000020 Funding Number: RFA OAA 14 000020 Agency: Agency for International Development Category: Health Funding Amount: $45,000,000 |
| Bridging the Word Gap Research Network Apply for HRSA 14 131 Funding Number: HRSA 14 131 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Complex Technologies and Therapeutics Development for Mental Health Research and Practice (R41/R42) Apply for PA 14 196 Funding Number: PA 14 196 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Complex Technologies and Therapeutics Development for Mental Health Research and Practice (R43/R44) Apply for PA 14 197 Funding Number: PA 14 197 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| EPT 2, One Health Workforce Apply for RFA OAA 14 000023 Funding Number: RFA OAA 14 000023 Agency: Agency for International Development Category: Health Funding Amount: $50,000,000 |
| American Indians Into Medicine Apply for HHS 2014 IHS INMED 0001 Funding Number: HHS 2014 IHS INMED 0001 Agency: Indian Health Service Category: Health Funding Amount: $195,000 |
| Unconventional Roles of Ethanol Metabolizing Enzymes, Metabolites, and Cofactors in Health and Disease (R01) Apply for PA 14 198 Funding Number: PA 14 198 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAMS Clinical Trial Implementation Cooperative Agreement (U01) Apply for PAR 14 200 Funding Number: PAR 14 200 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAMS Clinical Trial Planning Cooperative Agreement (U34) Apply for PAR 14 199 Funding Number: PAR 14 199 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Sudden Death in the Young (SDY) Registry Apply for CDC RFA DP14 1403 Funding Number: CDC RFA DP14 1403 Agency: NCCDPHP Category: Health Funding Amount: $200,000 |
| NEI Administrative Supplements to Small Business Innovative Research (SBIR) Grants for the Procurement of Expertise in the Federal Regulatory Approval Process for New Drugs and/or Devices (Admin Supp) Apply for PA 14 205 Funding Number: PA 14 205 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthening a network of immunization programs to support the NCIRD mission to prevent disease through immunization Apply for CDC RFA IP14 1402 Funding Number: CDC RFA IP14 1402 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $700,000 |
| Enhancing Cancer Registries for Early Case Capture (ECC) of Pediatric and Young Adult Cancer (PYAC) Cases Apply for CDC RFA DP14 1402 Funding Number: CDC RFA DP14 1402 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Enhancing Cancer Genomic Best Practices through Education, Surveillance, and Policy Apply for CDC RFA DP14 1407 Funding Number: CDC RFA DP14 1407 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| HIV Vaccine Research and Design (HIVRAD) Program (P01) Apply for PAR 14 206 Funding Number: PAR 14 206 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Protecting and Improving Public Health Globally Building and Strengthening Public Health Impact, Systems, Capacity and Security Apply for CDC RFA GH14 1418 Funding Number: CDC RFA GH14 1418 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01) Apply for PAR 14 207 Funding Number: PAR 14 207 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Longitudinal Assessment of Post traumatic Syndromes (U01) Apply for RFA MH 15 110 Funding Number: RFA MH 15 110 Agency: National Institutes of Health Category: Health Funding Amount: $5,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA IP14 1403", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.